Literature DB >> 36038425

Multi-bacillary leprosy under the Chinese leprosy elimination program.

Ge Li1, Chao Li2, Qingping Zhang3, Hong Zhang4, Ping Chen4, Zhaoxing Lin4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 36038425      PMCID： PMC9582880          DOI： 10.1016/j.abd.2021.08.012

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN： 0365-0596            Impact factor:   2.113


× No keyword cloud information.
  7 in total

1.  Global leprosy update, 2016: accelerating reduction of disease burden.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2017-09-01

2.  Chemotherapy of leprosy for control programmes.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1982

3.  Epidemiological situation of leprosy in a province in China: a long time to diagnosis and a high rate of deformity.

Authors:  Qing-Ping Zhang; Ge Li; Chao Li; Zhao-Xing Lin; Ping Chen
Journal:  BMC Public Health       Date:  2020-11-25       Impact factor: 3.295

4.  Active search for leprosy cases in Midwestern Brazil: a serological evaluation of asymptomatic household contacts before and after prophylaxis with bacillus Calmette-Guérin.

Authors:  Omesina Maroja Limeira; Ciro Martins Gomes; Orlando Oliveira de Morais; Mariana Vicente Cesetti; Rosicler Rocha Aiza Alvarez
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013       Impact factor: 1.846

Review 5.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Clinical and epidemiological profile of leprosy patients attended at Ceará, 2007-2011.

Authors:  Maria Iranilda Queirós; Alberto Novaes Ramos; Carlos Henrique Morais Alencar; Lorena Dias Monteiro; Amanda Lima Sena; Jaqueline Caracas Barbosa
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

7.  Risk factors for physical disability upon release from multidrug therapy in new cases of leprosy at a referral center in Brazil.

Authors:  Bárbara Proença Nardi Assis; Sandra Lyon; Maria Aparecida de Faria Grossi; Manoel Otávio da Costa Rocha
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-02-14       Impact factor: 1.846
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.